nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP1A2—Anagrelide—hematologic cancer	0.044	0.0709	CbGbCtD
Bupivacaine—CYP2D6—Lomustine—hematologic cancer	0.0233	0.0377	CbGbCtD
Bupivacaine—CYP1A2—Carmustine—hematologic cancer	0.0231	0.0373	CbGbCtD
Bupivacaine—CYP2D6—Idarubicin—hematologic cancer	0.0208	0.0336	CbGbCtD
Bupivacaine—CYP2C19—Bortezomib—hematologic cancer	0.0202	0.0327	CbGbCtD
Bupivacaine—CYP1A2—Methoxsalen—hematologic cancer	0.0196	0.0317	CbGbCtD
Bupivacaine—CYP1A2—Bortezomib—hematologic cancer	0.0187	0.0301	CbGbCtD
Bupivacaine—CYP1A2—Daunorubicin—hematologic cancer	0.0179	0.0288	CbGbCtD
Bupivacaine—CYP2D6—Hydroxyurea—hematologic cancer	0.0177	0.0285	CbGbCtD
Bupivacaine—CYP2C19—Thalidomide—hematologic cancer	0.0176	0.0285	CbGbCtD
Bupivacaine—CYP1A2—Alitretinoin—hematologic cancer	0.0175	0.0282	CbGbCtD
Bupivacaine—CYP2C19—Teniposide—hematologic cancer	0.0168	0.0271	CbGbCtD
Bupivacaine—CYP1A2—Thalidomide—hematologic cancer	0.0163	0.0263	CbGbCtD
Bupivacaine—CYP3A4—Bexarotene—hematologic cancer	0.016	0.0258	CbGbCtD
Bupivacaine—CYP2C19—Ifosfamide—hematologic cancer	0.0155	0.0251	CbGbCtD
Bupivacaine—CYP2D6—Bortezomib—hematologic cancer	0.0154	0.0248	CbGbCtD
Bupivacaine—CYP3A4—Lomustine—hematologic cancer	0.0148	0.0239	CbGbCtD
Bupivacaine—CYP3A4—Busulfan—hematologic cancer	0.0148	0.0239	CbGbCtD
Bupivacaine—CYP2C19—Imatinib—hematologic cancer	0.0148	0.0239	CbGbCtD
Bupivacaine—CYP1A2—Dacarbazine—hematologic cancer	0.014	0.0226	CbGbCtD
Bupivacaine—CYP1A2—Imatinib—hematologic cancer	0.0137	0.0221	CbGbCtD
Bupivacaine—CYP3A4—Thiotepa—hematologic cancer	0.0132	0.0213	CbGbCtD
Bupivacaine—CYP2D6—Imatinib—hematologic cancer	0.0113	0.0182	CbGbCtD
Bupivacaine—CYP1A2—Dasatinib—hematologic cancer	0.011	0.0177	CbGbCtD
Bupivacaine—CYP3A4—Methoxsalen—hematologic cancer	0.0103	0.0166	CbGbCtD
Bupivacaine—CYP2D6—Nilotinib—hematologic cancer	0.0102	0.0165	CbGbCtD
Bupivacaine—CYP2D6—Vinorelbine—hematologic cancer	0.0102	0.0164	CbGbCtD
Bupivacaine—CYP3A4—Bortezomib—hematologic cancer	0.00978	0.0158	CbGbCtD
Bupivacaine—CYP2C19—Prednisone—hematologic cancer	0.00977	0.0158	CbGbCtD
Bupivacaine—CYP3A4—Daunorubicin—hematologic cancer	0.00936	0.0151	CbGbCtD
Bupivacaine—CYP3A4—Cytarabine—hematologic cancer	0.00825	0.0133	CbGbCtD
Bupivacaine—CYP3A4—Teniposide—hematologic cancer	0.00813	0.0131	CbGbCtD
Bupivacaine—CYP3A4—Ifosfamide—hematologic cancer	0.0075	0.0121	CbGbCtD
Bupivacaine—CYP3A4—Imatinib—hematologic cancer	0.00717	0.0116	CbGbCtD
Bupivacaine—CYP1A2—Etoposide—hematologic cancer	0.00684	0.011	CbGbCtD
Bupivacaine—CYP3A4—Ruxolitinib—hematologic cancer	0.00675	0.0109	CbGbCtD
Bupivacaine—CYP3A4—Nilotinib—hematologic cancer	0.00651	0.0105	CbGbCtD
Bupivacaine—CYP3A4—Vinorelbine—hematologic cancer	0.00646	0.0104	CbGbCtD
Bupivacaine—CYP2D6—Vinblastine—hematologic cancer	0.00626	0.0101	CbGbCtD
Bupivacaine—CYP2C19—Dexamethasone—hematologic cancer	0.0061	0.00984	CbGbCtD
Bupivacaine—CYP3A4—Triamcinolone—hematologic cancer	0.00591	0.00953	CbGbCtD
Bupivacaine—CYP3A4—Dasatinib—hematologic cancer	0.00576	0.00929	CbGbCtD
Bupivacaine—CYP3A4—Mitoxantrone—hematologic cancer	0.00569	0.00918	CbGbCtD
Bupivacaine—CYP3A4—Betamethasone—hematologic cancer	0.00507	0.00818	CbGbCtD
Bupivacaine—CYP3A4—Prednisolone—hematologic cancer	0.005	0.00807	CbGbCtD
Bupivacaine—CYP3A4—Prednisone—hematologic cancer	0.00472	0.00762	CbGbCtD
Bupivacaine—CYP2D6—Dexamethasone—hematologic cancer	0.00464	0.00748	CbGbCtD
Bupivacaine—CYP3A4—Irinotecan—hematologic cancer	0.00448	0.00723	CbGbCtD
Bupivacaine—CYP3A4—Vinblastine—hematologic cancer	0.00398	0.00642	CbGbCtD
Bupivacaine—CYP3A4—Vincristine—hematologic cancer	0.00391	0.00632	CbGbCtD
Bupivacaine—CYP2D6—Doxorubicin—hematologic cancer	0.00385	0.00621	CbGbCtD
Bupivacaine—CYP3A4—Etoposide—hematologic cancer	0.00359	0.00579	CbGbCtD
Bupivacaine—CYP3A4—Dexamethasone—hematologic cancer	0.00295	0.00476	CbGbCtD
Bupivacaine—CYP3A4—Doxorubicin—hematologic cancer	0.00245	0.00395	CbGbCtD
Bupivacaine—Insomnia—Dexamethasone—hematologic cancer	3e-05	9.92e-05	CcSEcCtD
Bupivacaine—Insomnia—Betamethasone—hematologic cancer	3e-05	9.92e-05	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—hematologic cancer	3e-05	9.9e-05	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3e-05	9.89e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Dexamethasone—hematologic cancer	2.98e-05	9.85e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Betamethasone—hematologic cancer	2.98e-05	9.85e-05	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—hematologic cancer	2.98e-05	9.84e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Etoposide—hematologic cancer	2.97e-05	9.82e-05	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—hematologic cancer	2.97e-05	9.8e-05	CcSEcCtD
Bupivacaine—Malnutrition—Methotrexate—hematologic cancer	2.96e-05	9.78e-05	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—hematologic cancer	2.96e-05	9.78e-05	CcSEcCtD
Bupivacaine—Headache—Gemcitabine—hematologic cancer	2.96e-05	9.77e-05	CcSEcCtD
Bupivacaine—Nausea—Vincristine—hematologic cancer	2.96e-05	9.77e-05	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—hematologic cancer	2.95e-05	9.76e-05	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—hematologic cancer	2.95e-05	9.76e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Prednisolone—hematologic cancer	2.93e-05	9.68e-05	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.93e-05	9.68e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Dexamethasone—hematologic cancer	2.92e-05	9.65e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Betamethasone—hematologic cancer	2.92e-05	9.65e-05	CcSEcCtD
Bupivacaine—Urticaria—Triamcinolone—hematologic cancer	2.91e-05	9.6e-05	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—hematologic cancer	2.9e-05	9.58e-05	CcSEcCtD
Bupivacaine—Asthenia—Etoposide—hematologic cancer	2.9e-05	9.56e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Triamcinolone—hematologic cancer	2.89e-05	9.55e-05	CcSEcCtD
Bupivacaine—Oedema—Prednisone—hematologic cancer	2.89e-05	9.55e-05	CcSEcCtD
Bupivacaine—Anaphylactic shock—Prednisone—hematologic cancer	2.89e-05	9.55e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Betamethasone—hematologic cancer	2.89e-05	9.53e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Dexamethasone—hematologic cancer	2.89e-05	9.53e-05	CcSEcCtD
Bupivacaine—Nausea—Mitoxantrone—hematologic cancer	2.88e-05	9.51e-05	CcSEcCtD
Bupivacaine—Nausea—Irinotecan—hematologic cancer	2.88e-05	9.51e-05	CcSEcCtD
Bupivacaine—Infection—Prednisone—hematologic cancer	2.87e-05	9.49e-05	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.87e-05	9.47e-05	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.87e-05	9.47e-05	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—hematologic cancer	2.86e-05	9.46e-05	CcSEcCtD
Bupivacaine—Chills—Epirubicin—hematologic cancer	2.86e-05	9.43e-05	CcSEcCtD
Bupivacaine—Pruritus—Etoposide—hematologic cancer	2.85e-05	9.43e-05	CcSEcCtD
Bupivacaine—Shock—Prednisone—hematologic cancer	2.85e-05	9.39e-05	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—hematologic cancer	2.84e-05	9.39e-05	CcSEcCtD
Bupivacaine—Pain—Betamethasone—hematologic cancer	2.84e-05	9.38e-05	CcSEcCtD
Bupivacaine—Pain—Dexamethasone—hematologic cancer	2.84e-05	9.38e-05	CcSEcCtD
Bupivacaine—Nervous system disorder—Prednisone—hematologic cancer	2.84e-05	9.36e-05	CcSEcCtD
Bupivacaine—Tachycardia—Prednisone—hematologic cancer	2.82e-05	9.32e-05	CcSEcCtD
Bupivacaine—Skin disorder—Prednisone—hematologic cancer	2.81e-05	9.27e-05	CcSEcCtD
Bupivacaine—Nausea—Gemcitabine—hematologic cancer	2.81e-05	9.27e-05	CcSEcCtD
Bupivacaine—Vomiting—Cisplatin—hematologic cancer	2.8e-05	9.25e-05	CcSEcCtD
Bupivacaine—Hyperhidrosis—Prednisone—hematologic cancer	2.8e-05	9.23e-05	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—hematologic cancer	2.79e-05	9.21e-05	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—hematologic cancer	2.79e-05	9.21e-05	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—hematologic cancer	2.77e-05	9.15e-05	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—hematologic cancer	2.77e-05	9.15e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Etoposide—hematologic cancer	2.76e-05	9.12e-05	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—hematologic cancer	2.75e-05	9.07e-05	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—hematologic cancer	2.74e-05	9.04e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Betamethasone—hematologic cancer	2.74e-05	9.03e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Dexamethasone—hematologic cancer	2.74e-05	9.03e-05	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—hematologic cancer	2.73e-05	9.03e-05	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—hematologic cancer	2.73e-05	9.03e-05	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—hematologic cancer	2.73e-05	9.02e-05	CcSEcCtD
Bupivacaine—Tension—Epirubicin—hematologic cancer	2.72e-05	8.98e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.72e-05	8.97e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.72e-05	8.97e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Triamcinolone—hematologic cancer	2.7e-05	8.9e-05	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—hematologic cancer	2.69e-05	8.89e-05	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—hematologic cancer	2.68e-05	8.85e-05	CcSEcCtD
Bupivacaine—Dizziness—Etoposide—hematologic cancer	2.67e-05	8.81e-05	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—hematologic cancer	2.66e-05	8.8e-05	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—hematologic cancer	2.64e-05	8.73e-05	CcSEcCtD
Bupivacaine—Urticaria—Betamethasone—hematologic cancer	2.64e-05	8.71e-05	CcSEcCtD
Bupivacaine—Urticaria—Dexamethasone—hematologic cancer	2.64e-05	8.71e-05	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.64e-05	8.7e-05	CcSEcCtD
Bupivacaine—Dizziness—Prednisolone—hematologic cancer	2.63e-05	8.69e-05	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—hematologic cancer	2.63e-05	8.69e-05	CcSEcCtD
Bupivacaine—Asthenia—Triamcinolone—hematologic cancer	2.63e-05	8.67e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Dexamethasone—hematologic cancer	2.63e-05	8.67e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Betamethasone—hematologic cancer	2.63e-05	8.67e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Betamethasone—hematologic cancer	2.63e-05	8.67e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Dexamethasone—hematologic cancer	2.63e-05	8.67e-05	CcSEcCtD
Bupivacaine—Nausea—Cisplatin—hematologic cancer	2.62e-05	8.64e-05	CcSEcCtD
Bupivacaine—Insomnia—Prednisone—hematologic cancer	2.62e-05	8.64e-05	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—hematologic cancer	2.61e-05	8.62e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Prednisone—hematologic cancer	2.6e-05	8.57e-05	CcSEcCtD
Bupivacaine—Pruritus—Triamcinolone—hematologic cancer	2.59e-05	8.55e-05	CcSEcCtD
Bupivacaine—Cough—Methotrexate—hematologic cancer	2.58e-05	8.53e-05	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—hematologic cancer	2.58e-05	8.52e-05	CcSEcCtD
Bupivacaine—Convulsion—Methotrexate—hematologic cancer	2.57e-05	8.47e-05	CcSEcCtD
Bupivacaine—Vomiting—Etoposide—hematologic cancer	2.57e-05	8.47e-05	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—hematologic cancer	2.56e-05	8.47e-05	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—hematologic cancer	2.56e-05	8.47e-05	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—hematologic cancer	2.56e-05	8.46e-05	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—hematologic cancer	2.55e-05	8.41e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Prednisone—hematologic cancer	2.55e-05	8.4e-05	CcSEcCtD
Bupivacaine—Headache—Etoposide—hematologic cancer	2.53e-05	8.35e-05	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—hematologic cancer	2.53e-05	8.34e-05	CcSEcCtD
Bupivacaine—Arthralgia—Methotrexate—hematologic cancer	2.52e-05	8.32e-05	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—hematologic cancer	2.52e-05	8.31e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Prednisone—hematologic cancer	2.51e-05	8.3e-05	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.5e-05	8.27e-05	CcSEcCtD
Bupivacaine—Headache—Prednisolone—hematologic cancer	2.49e-05	8.23e-05	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—hematologic cancer	2.49e-05	8.22e-05	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—hematologic cancer	2.49e-05	8.21e-05	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—hematologic cancer	2.48e-05	8.19e-05	CcSEcCtD
Bupivacaine—Constipation—Prednisone—hematologic cancer	2.47e-05	8.17e-05	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—hematologic cancer	2.47e-05	8.14e-05	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—hematologic cancer	2.45e-05	8.09e-05	CcSEcCtD
Bupivacaine—Confusional state—Methotrexate—hematologic cancer	2.44e-05	8.05e-05	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—hematologic cancer	2.44e-05	8.04e-05	CcSEcCtD
Bupivacaine—Dizziness—Triamcinolone—hematologic cancer	2.42e-05	7.99e-05	CcSEcCtD
Bupivacaine—Cough—Epirubicin—hematologic cancer	2.42e-05	7.98e-05	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—hematologic cancer	2.42e-05	7.98e-05	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—hematologic cancer	2.42e-05	7.98e-05	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—hematologic cancer	2.4e-05	7.93e-05	CcSEcCtD
Bupivacaine—Infection—Methotrexate—hematologic cancer	2.4e-05	7.93e-05	CcSEcCtD
Bupivacaine—Nausea—Etoposide—hematologic cancer	2.4e-05	7.91e-05	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—hematologic cancer	2.39e-05	7.9e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Prednisone—hematologic cancer	2.38e-05	7.87e-05	CcSEcCtD
Bupivacaine—Asthenia—Dexamethasone—hematologic cancer	2.38e-05	7.87e-05	CcSEcCtD
Bupivacaine—Asthenia—Betamethasone—hematologic cancer	2.38e-05	7.87e-05	CcSEcCtD
Bupivacaine—Nervous system disorder—Methotrexate—hematologic cancer	2.37e-05	7.83e-05	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—hematologic cancer	2.37e-05	7.83e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Prednisone—hematologic cancer	2.37e-05	7.81e-05	CcSEcCtD
Bupivacaine—Nausea—Prednisolone—hematologic cancer	2.36e-05	7.8e-05	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—hematologic cancer	2.36e-05	7.79e-05	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—hematologic cancer	2.36e-05	7.78e-05	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—hematologic cancer	2.35e-05	7.76e-05	CcSEcCtD
Bupivacaine—Pruritus—Betamethasone—hematologic cancer	2.35e-05	7.76e-05	CcSEcCtD
Bupivacaine—Pruritus—Dexamethasone—hematologic cancer	2.35e-05	7.76e-05	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—hematologic cancer	2.35e-05	7.75e-05	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.34e-05	7.74e-05	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—hematologic cancer	2.34e-05	7.71e-05	CcSEcCtD
Bupivacaine—Vomiting—Triamcinolone—hematologic cancer	2.33e-05	7.68e-05	CcSEcCtD
Bupivacaine—Syncope—Doxorubicin—hematologic cancer	2.3e-05	7.59e-05	CcSEcCtD
Bupivacaine—Urticaria—Prednisone—hematologic cancer	2.3e-05	7.59e-05	CcSEcCtD
Bupivacaine—Headache—Triamcinolone—hematologic cancer	2.29e-05	7.57e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Prednisone—hematologic cancer	2.29e-05	7.55e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Prednisone—hematologic cancer	2.29e-05	7.55e-05	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—hematologic cancer	2.28e-05	7.53e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Betamethasone—hematologic cancer	2.27e-05	7.5e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Dexamethasone—hematologic cancer	2.27e-05	7.5e-05	CcSEcCtD
Bupivacaine—Palpitations—Doxorubicin—hematologic cancer	2.27e-05	7.48e-05	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—hematologic cancer	2.26e-05	7.47e-05	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—hematologic cancer	2.26e-05	7.47e-05	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—hematologic cancer	2.26e-05	7.46e-05	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—hematologic cancer	2.25e-05	7.44e-05	CcSEcCtD
Bupivacaine—Infection—Epirubicin—hematologic cancer	2.25e-05	7.42e-05	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—hematologic cancer	2.24e-05	7.39e-05	CcSEcCtD
Bupivacaine—Shock—Epirubicin—hematologic cancer	2.23e-05	7.35e-05	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—hematologic cancer	2.22e-05	7.34e-05	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—hematologic cancer	2.22e-05	7.32e-05	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—hematologic cancer	2.21e-05	7.31e-05	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—hematologic cancer	2.21e-05	7.29e-05	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.2e-05	7.27e-05	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—hematologic cancer	2.2e-05	7.25e-05	CcSEcCtD
Bupivacaine—Dizziness—Betamethasone—hematologic cancer	2.2e-05	7.25e-05	CcSEcCtD
Bupivacaine—Dizziness—Dexamethasone—hematologic cancer	2.2e-05	7.25e-05	CcSEcCtD
Bupivacaine—Hyperhidrosis—Epirubicin—hematologic cancer	2.19e-05	7.22e-05	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—hematologic cancer	2.19e-05	7.22e-05	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—hematologic cancer	2.18e-05	7.21e-05	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—hematologic cancer	2.18e-05	7.18e-05	CcSEcCtD
Bupivacaine—Nausea—Triamcinolone—hematologic cancer	2.17e-05	7.18e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—hematologic cancer	2.17e-05	7.17e-05	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.17e-05	7.16e-05	CcSEcCtD
Bupivacaine—Dyspnoea—Methotrexate—hematologic cancer	2.15e-05	7.11e-05	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—hematologic cancer	2.15e-05	7.09e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Prednisone—hematologic cancer	2.13e-05	7.03e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—hematologic cancer	2.13e-05	7.02e-05	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—hematologic cancer	2.11e-05	6.98e-05	CcSEcCtD
Bupivacaine—Vomiting—Dexamethasone—hematologic cancer	2.11e-05	6.97e-05	CcSEcCtD
Bupivacaine—Vomiting—Betamethasone—hematologic cancer	2.11e-05	6.97e-05	CcSEcCtD
Bupivacaine—Confusional state—Doxorubicin—hematologic cancer	2.11e-05	6.97e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Methotrexate—hematologic cancer	2.1e-05	6.94e-05	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.09e-05	6.91e-05	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—hematologic cancer	2.09e-05	6.91e-05	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.09e-05	6.89e-05	CcSEcCtD
Bupivacaine—Headache—Dexamethasone—hematologic cancer	2.08e-05	6.87e-05	CcSEcCtD
Bupivacaine—Headache—Betamethasone—hematologic cancer	2.08e-05	6.87e-05	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—hematologic cancer	2.08e-05	6.86e-05	CcSEcCtD
Bupivacaine—Asthenia—Prednisone—hematologic cancer	2.08e-05	6.85e-05	CcSEcCtD
Bupivacaine—Pain—Methotrexate—hematologic cancer	2.07e-05	6.82e-05	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.06e-05	6.8e-05	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—hematologic cancer	2.06e-05	6.8e-05	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—hematologic cancer	2.05e-05	6.78e-05	CcSEcCtD
Bupivacaine—Pruritus—Prednisone—hematologic cancer	2.05e-05	6.76e-05	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—hematologic cancer	2.05e-05	6.75e-05	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—hematologic cancer	2.04e-05	6.74e-05	CcSEcCtD
Bupivacaine—Skin disorder—Doxorubicin—hematologic cancer	2.03e-05	6.71e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—hematologic cancer	2.03e-05	6.71e-05	CcSEcCtD
Bupivacaine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.02e-05	6.68e-05	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—hematologic cancer	2.02e-05	6.66e-05	CcSEcCtD
Bupivacaine—Somnolence—Epirubicin—hematologic cancer	2.01e-05	6.64e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Methotrexate—hematologic cancer	1.99e-05	6.58e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—hematologic cancer	1.99e-05	6.57e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Prednisone—hematologic cancer	1.98e-05	6.53e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.98e-05	6.53e-05	CcSEcCtD
Bupivacaine—Nausea—Betamethasone—hematologic cancer	1.97e-05	6.51e-05	CcSEcCtD
Bupivacaine—Nausea—Dexamethasone—hematologic cancer	1.97e-05	6.51e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—hematologic cancer	1.97e-05	6.49e-05	CcSEcCtD
Bupivacaine—Hypotension—Doxorubicin—hematologic cancer	1.96e-05	6.46e-05	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.95e-05	6.45e-05	CcSEcCtD
Bupivacaine—Pain—Epirubicin—hematologic cancer	1.93e-05	6.39e-05	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—hematologic cancer	1.93e-05	6.39e-05	CcSEcCtD
Bupivacaine—Urticaria—Methotrexate—hematologic cancer	1.92e-05	6.34e-05	CcSEcCtD
Bupivacaine—Dizziness—Prednisone—hematologic cancer	1.91e-05	6.31e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—hematologic cancer	1.91e-05	6.31e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—hematologic cancer	1.91e-05	6.31e-05	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.91e-05	6.3e-05	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—hematologic cancer	1.89e-05	6.25e-05	CcSEcCtD
Bupivacaine—Paraesthesia—Doxorubicin—hematologic cancer	1.88e-05	6.2e-05	CcSEcCtD
Bupivacaine—Dyspnoea—Doxorubicin—hematologic cancer	1.87e-05	6.16e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—hematologic cancer	1.86e-05	6.15e-05	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—hematologic cancer	1.86e-05	6.14e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.85e-05	6.11e-05	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—hematologic cancer	1.84e-05	6.08e-05	CcSEcCtD
Bupivacaine—Vomiting—Prednisone—hematologic cancer	1.84e-05	6.07e-05	CcSEcCtD
Bupivacaine—Decreased appetite—Doxorubicin—hematologic cancer	1.82e-05	6.01e-05	CcSEcCtD
Bupivacaine—Headache—Prednisone—hematologic cancer	1.81e-05	5.98e-05	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.81e-05	5.97e-05	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—hematologic cancer	1.8e-05	5.93e-05	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—hematologic cancer	1.79e-05	5.91e-05	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—hematologic cancer	1.79e-05	5.91e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—hematologic cancer	1.79e-05	5.9e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—hematologic cancer	1.79e-05	5.9e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Methotrexate—hematologic cancer	1.78e-05	5.88e-05	CcSEcCtD
Bupivacaine—Asthenia—Methotrexate—hematologic cancer	1.73e-05	5.73e-05	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—hematologic cancer	1.72e-05	5.69e-05	CcSEcCtD
Bupivacaine—Nausea—Prednisone—hematologic cancer	1.72e-05	5.67e-05	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.71e-05	5.65e-05	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—hematologic cancer	1.71e-05	5.65e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Epirubicin—hematologic cancer	1.67e-05	5.5e-05	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—hematologic cancer	1.66e-05	5.49e-05	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—hematologic cancer	1.65e-05	5.46e-05	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—hematologic cancer	1.65e-05	5.46e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Methotrexate—hematologic cancer	1.65e-05	5.46e-05	CcSEcCtD
Bupivacaine—Asthenia—Epirubicin—hematologic cancer	1.62e-05	5.36e-05	CcSEcCtD
Bupivacaine—Pruritus—Epirubicin—hematologic cancer	1.6e-05	5.28e-05	CcSEcCtD
Bupivacaine—Dizziness—Methotrexate—hematologic cancer	1.6e-05	5.28e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Epirubicin—hematologic cancer	1.55e-05	5.11e-05	CcSEcCtD
Bupivacaine—Hypersensitivity—Doxorubicin—hematologic cancer	1.54e-05	5.09e-05	CcSEcCtD
Bupivacaine—Vomiting—Methotrexate—hematologic cancer	1.54e-05	5.07e-05	CcSEcCtD
Bupivacaine—Headache—Methotrexate—hematologic cancer	1.51e-05	5e-05	CcSEcCtD
Bupivacaine—Asthenia—Doxorubicin—hematologic cancer	1.5e-05	4.96e-05	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—hematologic cancer	1.5e-05	4.94e-05	CcSEcCtD
Bupivacaine—Pruritus—Doxorubicin—hematologic cancer	1.48e-05	4.89e-05	CcSEcCtD
Bupivacaine—Vomiting—Epirubicin—hematologic cancer	1.44e-05	4.75e-05	CcSEcCtD
Bupivacaine—Nausea—Methotrexate—hematologic cancer	1.44e-05	4.74e-05	CcSEcCtD
Bupivacaine—Diarrhoea—Doxorubicin—hematologic cancer	1.43e-05	4.73e-05	CcSEcCtD
Bupivacaine—Headache—Epirubicin—hematologic cancer	1.42e-05	4.68e-05	CcSEcCtD
Bupivacaine—Dizziness—Doxorubicin—hematologic cancer	1.38e-05	4.57e-05	CcSEcCtD
Bupivacaine—Nausea—Epirubicin—hematologic cancer	1.34e-05	4.44e-05	CcSEcCtD
Bupivacaine—Vomiting—Doxorubicin—hematologic cancer	1.33e-05	4.39e-05	CcSEcCtD
Bupivacaine—Headache—Doxorubicin—hematologic cancer	1.31e-05	4.33e-05	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—CREB1—hematologic cancer	1.25e-05	0.000162	CbGpPWpGaD
Bupivacaine—Nausea—Doxorubicin—hematologic cancer	1.24e-05	4.1e-05	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—BRAF—hematologic cancer	1.24e-05	0.00016	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCL2—hematologic cancer	1.23e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMMR—hematologic cancer	1.22e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—IDH2—hematologic cancer	1.22e-05	0.000158	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6R—hematologic cancer	1.22e-05	0.000158	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CREBBP—hematologic cancer	1.22e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.21e-05	0.000156	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.2e-05	0.000155	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.2e-05	0.000155	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—DCK—hematologic cancer	1.2e-05	0.000155	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.19e-05	0.000153	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAP2K1—hematologic cancer	1.17e-05	0.000151	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CD—hematologic cancer	1.16e-05	0.00015	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.15e-05	0.000149	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTAP—hematologic cancer	1.15e-05	0.000149	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.15e-05	0.000148	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.15e-05	0.000148	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HDC—hematologic cancer	1.14e-05	0.000147	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—KRAS—hematologic cancer	1.13e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.13e-05	0.000145	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.13e-05	0.000145	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ACP5—hematologic cancer	1.12e-05	0.000144	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA9—hematologic cancer	1.12e-05	0.000144	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGF2—hematologic cancer	1.11e-05	0.000143	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.1e-05	0.000143	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3R1—hematologic cancer	1.09e-05	0.000141	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JAK2—hematologic cancer	1.06e-05	0.000137	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.06e-05	0.000137	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—IDH1—hematologic cancer	1.05e-05	0.000136	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CDA—hematologic cancer	1.04e-05	0.000135	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CA—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCC3—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTO1—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TXN—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MDM2—hematologic cancer	1.04e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA9—hematologic cancer	1.03e-05	0.000133	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.03e-05	0.000133	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—FHL2—hematologic cancer	1.03e-05	0.000132	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SPHK1—hematologic cancer	1.02e-05	0.000131	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.02e-05	0.000131	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MTOR—hematologic cancer	1.01e-05	0.00013	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CB—hematologic cancer	1.01e-05	0.00013	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AGRN—hematologic cancer	1.01e-05	0.00013	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PC—hematologic cancer	1.01e-05	0.00013	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—UGT1A1—hematologic cancer	9.78e-06	0.000126	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GBA—hematologic cancer	9.71e-06	0.000125	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	9.71e-06	0.000125	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—IDH1—hematologic cancer	9.68e-06	0.000125	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—HRAS—hematologic cancer	9.64e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TXN—hematologic cancer	9.57e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCC3—hematologic cancer	9.57e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTO1—hematologic cancer	9.57e-06	0.000124	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMMR—hematologic cancer	9.53e-06	0.000123	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—IDH2—hematologic cancer	9.53e-06	0.000123	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CRABP1—hematologic cancer	9.52e-06	0.000123	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC22A1—hematologic cancer	9.52e-06	0.000123	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1B—hematologic cancer	9.48e-06	0.000122	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AKT1—hematologic cancer	9.37e-06	0.000121	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SPHK1—hematologic cancer	9.36e-06	0.000121	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CASP3—hematologic cancer	9.29e-06	0.00012	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALOX5—hematologic cancer	9.27e-06	0.00012	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2—hematologic cancer	9.27e-06	0.00012	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—hematologic cancer	9.23e-06	0.000119	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—hematologic cancer	9.04e-06	0.000117	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JUN—hematologic cancer	9.02e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	9e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.99e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NUP98—hematologic cancer	8.98e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ARNTL—hematologic cancer	8.96e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTAP—hematologic cancer	8.88e-06	0.000115	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	8.75e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CRABP1—hematologic cancer	8.75e-06	0.000113	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1A—hematologic cancer	8.74e-06	0.000113	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTEN—hematologic cancer	8.72e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA9—hematologic cancer	8.72e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ACP5—hematologic cancer	8.72e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ADCY7—hematologic cancer	8.72e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOA3—hematologic cancer	8.72e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NUP214—hematologic cancer	8.66e-06	0.000112	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOR2—hematologic cancer	8.61e-06	0.000111	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.57e-06	0.000111	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK8—hematologic cancer	8.53e-06	0.00011	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALOX5—hematologic cancer	8.53e-06	0.00011	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—hematologic cancer	8.51e-06	0.00011	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCG2—hematologic cancer	8.48e-06	0.000109	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTR—hematologic cancer	8.48e-06	0.000109	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EP300—hematologic cancer	8.32e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO2—hematologic cancer	8.32e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NUP98—hematologic cancer	8.26e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—IDH1—hematologic cancer	8.2e-06	0.000106	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCC3—hematologic cancer	8.11e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTO1—hematologic cancer	8.11e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TXN—hematologic cancer	8.11e-06	0.000105	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SRC—hematologic cancer	8.09e-06	0.000104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—hematologic cancer	8.07e-06	0.000104	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.02e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.02e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NUP214—hematologic cancer	7.96e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.94e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SPHK1—hematologic cancer	7.93e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—FHL2—hematologic cancer	7.91e-06	0.000102	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SDC1—hematologic cancer	7.88e-06	0.000102	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—hematologic cancer	7.88e-06	0.000102	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—hematologic cancer	7.8e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.8e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTR—hematologic cancer	7.8e-06	0.000101	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NRAS—hematologic cancer	7.78e-06	0.0001	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AGRN—hematologic cancer	7.76e-06	0.0001	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO2—hematologic cancer	7.65e-06	9.87e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	7.62e-06	9.84e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.53e-06	9.72e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK3—hematologic cancer	7.45e-06	9.62e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.43e-06	9.6e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.42e-06	9.58e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.41e-06	9.57e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.41e-06	9.57e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—IDH2—hematologic cancer	7.36e-06	9.5e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMMR—hematologic cancer	7.36e-06	9.5e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SDC1—hematologic cancer	7.25e-06	9.36e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—hematologic cancer	7.25e-06	9.36e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—hematologic cancer	7.23e-06	9.34e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALOX5—hematologic cancer	7.23e-06	9.33e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.11e-06	9.18e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NUP98—hematologic cancer	7e-06	9.03e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.92e-06	8.93e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ADCY7—hematologic cancer	6.79e-06	8.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOA3—hematologic cancer	6.79e-06	8.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NUP214—hematologic cancer	6.75e-06	8.71e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA9—hematologic cancer	6.73e-06	8.69e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ACP5—hematologic cancer	6.73e-06	8.69e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CD44—hematologic cancer	6.7e-06	8.65e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NQO1—hematologic cancer	6.7e-06	8.65e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—hematologic cancer	6.7e-06	8.65e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.68e-06	8.62e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.64e-06	8.57e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.61e-06	8.53e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTR—hematologic cancer	6.61e-06	8.53e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.56e-06	8.47e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO2—hematologic cancer	6.48e-06	8.36e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYCS—hematologic cancer	6.34e-06	8.19e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—IDH1—hematologic cancer	6.33e-06	8.17e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	6.3e-06	8.14e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—hematologic cancer	6.29e-06	8.11e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TXN—hematologic cancer	6.26e-06	8.07e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.26e-06	8.07e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.26e-06	8.07e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.19e-06	7.99e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CD44—hematologic cancer	6.17e-06	7.96e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NQO1—hematologic cancer	6.17e-06	7.96e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—hematologic cancer	6.15e-06	7.94e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SDC1—hematologic cancer	6.14e-06	7.93e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.12e-06	7.9e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—hematologic cancer	5.95e-06	7.69e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.88e-06	7.59e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.87e-06	7.57e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.83e-06	7.53e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.8e-06	7.48e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.79e-06	7.48e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.72e-06	7.39e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.72e-06	7.39e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HRAS—hematologic cancer	5.69e-06	7.35e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.67e-06	7.32e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.59e-06	7.22e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.58e-06	7.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.54e-06	7.15e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—hematologic cancer	5.45e-06	7.03e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.41e-06	6.98e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NUP98—hematologic cancer	5.4e-06	6.97e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCB1—hematologic cancer	5.29e-06	6.83e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.24e-06	6.77e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.24e-06	6.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NQO1—hematologic cancer	5.22e-06	6.74e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CD44—hematologic cancer	5.22e-06	6.74e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NUP214—hematologic cancer	5.21e-06	6.72e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.14e-06	6.64e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.14e-06	6.63e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.14e-06	6.63e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.11e-06	6.6e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTR—hematologic cancer	5.1e-06	6.58e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.1e-06	6.58e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—hematologic cancer	5.03e-06	6.49e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO2—hematologic cancer	5e-06	6.46e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYCS—hematologic cancer	4.94e-06	6.38e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.91e-06	6.34e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.87e-06	6.28e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.85e-06	6.26e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.74e-06	6.12e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.73e-06	6.1e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.73e-06	6.1e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.54e-06	5.86e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.42e-06	5.7e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.36e-06	5.62e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.22e-06	5.44e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.18e-06	5.39e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.12e-06	5.32e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.03e-06	5.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CD44—hematologic cancer	4.03e-06	5.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—hematologic cancer	4e-06	5.17e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOR1—hematologic cancer	4e-06	5.17e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4e-06	5.17e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.82e-06	4.92e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.81e-06	4.92e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.79e-06	4.89e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.54e-06	4.57e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.54e-06	4.57e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.51e-06	4.53e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.36e-06	4.34e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.35e-06	4.33e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALB—hematologic cancer	3.31e-06	4.27e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.25e-06	4.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.18e-06	4.11e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.17e-06	4.09e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.12e-06	4.02e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.09e-06	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.09e-06	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.08e-06	3.98e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALB—hematologic cancer	3.05e-06	3.93e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.97e-06	3.84e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.92e-06	3.77e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.91e-06	3.76e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.76e-06	3.56e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.73e-06	3.52e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.69e-06	3.47e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.61e-06	3.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALB—hematologic cancer	2.58e-06	3.33e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.53e-06	3.26e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.47e-06	3.19e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—EP300—hematologic cancer	2.41e-06	3.11e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.32e-06	3e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.29e-06	2.96e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.28e-06	2.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—EP300—hematologic cancer	2.22e-06	2.86e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.13e-06	2.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.02e-06	2.6e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALB—hematologic cancer	1.99e-06	2.57e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.97e-06	2.54e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.9e-06	2.46e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—EP300—hematologic cancer	1.88e-06	2.42e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.78e-06	2.3e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.76e-06	2.27e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.64e-06	2.12e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.52e-06	1.96e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.46e-06	1.88e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—EP300—hematologic cancer	1.45e-06	1.87e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.39e-06	1.79e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.34e-06	1.73e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.13e-06	1.46e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.38e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.76e-07	1.13e-05	CbGpPWpGaD
